Raia Drogasil (BSP:RADL3) Beginning Cash Position: R$510 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:RADL3 Raia Drogasil SA BSP:RADL3
91 GF Score
Price R$18.20
GF Value R$30.07
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Raia Drogasil Beginning Cash Position?

Raia Drogasil BSP:RADL3 +0.17% 91 Beginning Cash Position is R$510 Mil as of Mar. 2026. GuruFocus rates BSP:RADL3 with a GF Score™ of 91/100 and a GF Value™ of R$30.07 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Raia Drogasil's Beginning Cash Position for the quarter that ended in Mar. 2026 was R$510 Mil.

Raia Drogasil's quarterly Beginning Cash Position declined from Sep. 2025 (R$527 Mil) to Dec. 2025 (R$436 Mil) but then increased from Dec. 2025 (R$436 Mil) to Mar. 2026 (R$510 Mil).

Raia Drogasil's annual Beginning Cash Position declined from Dec. 2023 (R$434 Mil) to Dec. 2024 (R$412 Mil) but then increased from Dec. 2024 (R$412 Mil) to Dec. 2025 (R$528 Mil).

Raia Drogasil Beginning Cash Position Related Terms

Raia Drogasil Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Raia Drogasil's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raia Drogasil Beginning Cash Position Chart

Raia Drogasil Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 880.36 356.12 433.54 412.32 528.00

Raia Drogasil Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 528.00 404.38 527.02 436.34 509.62
BSP:RADL3
91GF Score
Raia Drogasil SA BSP:RADL3
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raia Drogasil Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of R$510 Mil mean?
Raia Drogasil (BSP:RADL3) has a Beginning Cash Position of R$510 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Raia Drogasil and its competitors.
Is Raia Drogasil's Beginning Cash Position too high?
Raia Drogasil's current Beginning Cash Position is R$510 Mil. Overall, Raia Drogasil has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raia Drogasil's Beginning Cash Position compare to competitors?
Raia Drogasil's Beginning Cash Position of R$510 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Healthcare Providers & Services company?
A good Beginning Cash Position depends on the Healthcare Providers & Services industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Raia Drogasil and its competitors. Raia Drogasil's current Beginning Cash Position is R$510 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raia Drogasil stock overvalued right now?
Based on GuruFocus' analysis, Raia Drogasil (BSP:RADL3) is currently considered Significantly Undervalued. The stock's GF Value™ is R$30.07, compared to a current price of R$18.20 — trading 39.5% below its estimated fair value. The current Beginning Cash Position is R$510 Mil. Raia Drogasil's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Raia Drogasil (BSP:RADL3), the current Beginning Cash Position is R$510 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raia Drogasil (BSP:RADL3) Overvalued in 2026?

Based on GuruFocus' analysis, Raia Drogasil stock appears to be undervalued. The current stock price of R$18.20 is trading 39.5% below its estimated GF Value™ of R$30.07. GuruFocus considers Raia Drogasil to be Significantly Undervalued.

Key valuation signals for BSP:RADL3:

  • Beginning Cash Position: R$510 Mil
  • GF Value™: R$30.07 vs. price of R$18.20 (39.5% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the BSP:RADL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Raia Drogasil Business Description

Other Exchanges RADLY:USA
Address Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-900
Raia Drogasil SA operates a chain of pharmacies in Brazil. The company is mainly engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its pharmacies mainly operate under the Drogasil and Raia brands.
91GF Score

Get the complete analysis for BSP:RADL3

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$18.20
Price
R$30.07
GF Value